Achieve new breakthroughs in RNA
Design and develop next-generation RNA therapeutics more efficiently on the only R&D cloud platform to offer a complete RNA solution.
Request a demoRNA Therapeutics R&D Solutions
Benchling's RNA Therapeutics Solution was developed in partnership with leading industry innovators. For the first time, R&D teams can design natural and chemically modified oligonucleotides, mRNA, and other RNA sequences in a single solution. They can also centralize experimental results, standardize on syntax, and collaborate with teammates more effectively on a single platform.
Benefits
Simplify collaboration across multidisciplinary teams
Scientists design oligos with intuitive design tools, centralize experimental data, standardize sequence design, and establish a scalable common language across organizations.
Improve data quality and real-time scientific insights
Scientists keep consistent records across experiments, automatically centralize all key results, and aggregate results from diverse assays for real-time visualization in-platform.
Accelerate the speed of the entire RNA therapeutic lifecycle
Scientists and executives quickly track oligo modifications and consequent impact on biological activity to rapidly iterate on oligo candidates with customizable decision support tools.
Capabilities
Design chemically modified mRNA / RNA
Combine chemical modifications with sequence features in the same view with intuitive visualization. Ensure the sequences you design are unique and avoid duplication of effort by automatically checking for uniqueness during sequence registration.
Analyze RNA sequences
Leverage a full suite of RNA sequence analysis tools such as annotations, translations, primers, and alignments in one cohesive solution.
RNA research at scale
Benchling enables RNA entity management and design at scale using self-managed tenant-specific monomer libraries and allowing users to bulk modify oligo entities with pre-saved templates.
Capture data against RNA and small molecules
Improve data integrity and reduce repeat work. With results tables that link experimental and analytical data automatically against registered RNA sequences, monomers, ligands, or other stored small molecule entities, you can standardize data capture across scientists.
Improve traceability of RNA and related samples
Customize data models to fit your unique science and inventory hierarchy. The interlinking of stored entities and samples improves traceability and lineage tracking across monomers, ligands, small molecules, RNA sequences, batches, containers, and other inventory items.
Connect results with structure for deeper insights
Aggregate results across experiments, teams, RNA sequences, and small molecule entities in a central data warehouse. Visualize that data natively on Benchling so you quickly draw conclusions that support decisions without manually aggregating data from disparate sources.
“At Ribometrix we use specialized technology to identify therapeutically compelling RNAs. With Benchling, we have manageable uniqueness verification processes that gives our scientists access to the same data.”
Katie Warner — VP, RNA Biology, Ribometrix
Accelerators
The RNA Therapeutics R&D Accelerators provide best practices that shorten time-to-value.
Data model
Entity relationship diagram (ERD) which serves as an implementation blueprint
Tenant configuration
Pre-defined configuration using templates and dashboards for registering entities and streamlining workflows
Solution Guide
Highlights capabilities and latest product features to maximize your Benchling investment
Design, analyze, and develop RNA therapeutics on Benchling
Trusted by the world's leading RNA innovators
Request a demo